Latest Breaking News On - Dieter weinand - Page 1 : comparemela.com

DISCO Pharmaceuticals Launches As The Surfaceome Company With EUR 20 Million In Seed Financing

DISCO Pharmaceuticals Launches As The Surfaceome Company With EUR 20 Million In Seed Financing
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Johannes heuckmannCarsten reinhardtMaina bhamanRoman thomasDieter weinandBernd wollscheidInternational medical leader at hoffmannUniversity of cologneStanford universityBayer pharmaceuticalsMicromet incSmall cell lung cancerIndependent directorSofinnova partnersPanakes partnersMicrosatellite stable colorectal cancer

Disco gets down with 20M EUR to find targets for cancer therapy

Disco gets down with 20M EUR to find targets for cancer therapy
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Roman thomasAntoine papiernikDieter weinandDisco pharmaceuticalsCologne universityBig pharmaAbbvie venturesPanakes partnersFierce biotech

DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed Financing

Transformative surfaceome discovery technology enables a comprehensive map of the cancer cell surface to identify a multitude of novel druggable targets..

Dieter weinandCarsten reinhardtMaina bhamanJohannes heuckmannBernd wollscheidRoman thomasInternational medical leader at hoffmannStanford universityUniversity of cologneBayer pharmaceuticalsMicromet incSmall cell lung cancerMicrosatellite stable colorectalIndependent directorSofinnova partnersPanakes partners

AbbVie-Backed Disco Launches with $20M in Funding, Targets Oncology

Disco Pharmaceuticals is taking to the biotech dance floor with seed funding from major players and pipeline programs in small cell lung cancer and colorectal cancer.

Johannes heuckmannDieter weinandRoman thomasBernd wollscheidUniversity of cologneDisco pharmaceuticalsStanford universityBayer pharmaceuticalsAbbvie venturesPanakes partnersSofinnova partnersStefan riesVersant venturesBbvie backed disco launches with 20m in fundingArgets oncology

Coya Therapeutics, Inc Provides Business Update and Reports Q3 2023 Unaudited Financial Results

Coya Therapeutics, Inc. , a clinical-stage biotechnology company developing biologics and cell therapies intended to enhance the function of Regulatory T Cells , today announced its financial.

United statesAlireza faridarEli lillyHoward bermanPhil campbellDieter weinandStanley appelTreg exosomesFred grossmanResearch collaboration agreementBristol myers squibbCarnegie mellon universityAlzheimer association international conferenceInternational conference on alzheimerWeill cornell medical collegeConsortium meeting on